rs2353005

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001098633.4(AKT1S1):​c.*412C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.103 in 158,598 control chromosomes in the GnomAD database, including 1,018 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.10 ( 947 hom., cov: 33)
Exomes 𝑓: 0.12 ( 71 hom. )

Consequence

AKT1S1
NM_001098633.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.776

Publications

19 publications found
Variant links:
Genes affected
AKT1S1 (HGNC:28426): (AKT1 substrate 1) AKT1S1 is a proline-rich substrate of AKT (MIM 164730) that binds 14-3-3 protein (see YWHAH, MIM 113508) when phosphorylated (Kovacina et al., 2003 [PubMed 12524439]).[supplied by OMIM, Mar 2008]
PNKP (HGNC:9154): (polynucleotide kinase 3'-phosphatase) This locus represents a gene involved in DNA repair. In response to ionizing radiation or oxidative damage, the protein encoded by this locus catalyzes 5' phosphorylation and 3' dephosphorylation of nucleic acids. Mutations at this locus have been associated with microcephaly, seizures, and developmental delay.[provided by RefSeq, Sep 2010]
PNKP Gene-Disease associations (from GenCC):
  • ataxia - oculomotor apraxia type 4
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, Laboratory for Molecular Medicine
  • microcephaly, seizures, and developmental delay
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Charcot-Marie-Tooth disease type 2B2
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.141 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AKT1S1NM_001098633.4 linkc.*412C>T 3_prime_UTR_variant Exon 5 of 5 ENST00000344175.10 NP_001092103.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AKT1S1ENST00000344175.10 linkc.*412C>T 3_prime_UTR_variant Exon 5 of 5 3 NM_001098633.4 ENSP00000341698.5

Frequencies

GnomAD3 genomes
AF:
0.102
AC:
15487
AN:
152190
Hom.:
949
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0365
Gnomad AMI
AF:
0.126
Gnomad AMR
AF:
0.0926
Gnomad ASJ
AF:
0.111
Gnomad EAS
AF:
0.122
Gnomad SAS
AF:
0.0912
Gnomad FIN
AF:
0.0888
Gnomad MID
AF:
0.0918
Gnomad NFE
AF:
0.144
Gnomad OTH
AF:
0.112
GnomAD4 exome
AF:
0.125
AC:
786
AN:
6290
Hom.:
71
Cov.:
0
AF XY:
0.123
AC XY:
405
AN XY:
3284
show subpopulations
African (AFR)
AF:
0.0504
AC:
12
AN:
238
American (AMR)
AF:
0.0556
AC:
7
AN:
126
Ashkenazi Jewish (ASJ)
AF:
0.117
AC:
27
AN:
230
East Asian (EAS)
AF:
0.124
AC:
30
AN:
242
South Asian (SAS)
AF:
0.0896
AC:
55
AN:
614
European-Finnish (FIN)
AF:
0.103
AC:
49
AN:
478
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
30
European-Non Finnish (NFE)
AF:
0.142
AC:
562
AN:
3956
Other (OTH)
AF:
0.117
AC:
44
AN:
376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
34
68
102
136
170
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.102
AC:
15477
AN:
152308
Hom.:
947
Cov.:
33
AF XY:
0.0991
AC XY:
7382
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0364
AC:
1512
AN:
41576
American (AMR)
AF:
0.0923
AC:
1413
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.111
AC:
384
AN:
3472
East Asian (EAS)
AF:
0.122
AC:
630
AN:
5178
South Asian (SAS)
AF:
0.0919
AC:
444
AN:
4830
European-Finnish (FIN)
AF:
0.0888
AC:
943
AN:
10618
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.144
AC:
9774
AN:
68014
Other (OTH)
AF:
0.111
AC:
235
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
725
1451
2176
2902
3627
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
190
380
570
760
950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.130
Hom.:
2373
Bravo
AF:
0.101
Asia WGS
AF:
0.0910
AC:
318
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.47
DANN
Benign
0.69
PhyloP100
-0.78
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2353005; hg19: chr19-50372762; API